CASP3 and infection: However, comparison with bone marrow-derived macrophages treated with TNF and SMAC mimetics (inhibiting XIAP, cIAP1/2 and thereby activating caspases) as a positive control71, revealed that caspase-3 was not fully processed to its p17 form during infection in vivo.